HUA SHAN, MD, PHD

Corporate Board Profile

Tech Score: 0/100

CERUS CORP

Filing Date	Source Excerpt
2023-04-28	Hua Shan, MD, PhD, 62, has served as a member of our Board since July 2022. Dr. Shan is a member of editorial boards of several leading international journals including Transfusion and Transfusion Medicine Review. Dr. Shan is a member of the ISBT’s Transfusion-Transmitted Infectious Diseases Working Party and AABB’s Clinical Transfusion Medicine Committee.
2024-04-26	Hua Shan, MD, PhD, 65, has served as a member of our Board since July 2022. ... In addition, in 2023, Dr. Shan provided certain consulting services related to our China joint venture and advocacy with Chinese regulatory bodies for approval of the INTERCEPT Bloody System in China. ... Dr. Shan was also engaged as a speaker to discuss her organization’s (the Stanford University Medical Center) experience utilizing the INTERCEPT Blood System for platelets. ... Dr. Shan was compensated $37,692 for consulting services in 2023. ... Under our director compensation program in effect for 2023, each non-employee director was entitled to an annual grant of RSUs on the date of each of our annual meetings ... Dr. Shan did not receive an RSU grant in 2023. ... The total for Dr. Shan is $82,692.

Filing Date

Source Excerpt

2023-04-28

Hua Shan, MD, PhD, 62, has served as a member of our Board since July 2022. Dr. Shan is a member of editorial boards of several leading international journals including Transfusion and Transfusion Medicine Review. Dr. Shan is a member of the ISBT’s Transfusion-Transmitted Infectious Diseases Working Party and AABB’s Clinical Transfusion Medicine Committee.

2024-04-26

Hua Shan, MD, PhD, 65, has served as a member of our Board since July 2022. ... In addition, in 2023, Dr. Shan provided certain consulting services related to our China joint venture and advocacy with Chinese regulatory bodies for approval of the INTERCEPT Bloody System in China. ... Dr. Shan was also engaged as a speaker to discuss her organization’s (the Stanford University Medical Center) experience utilizing the INTERCEPT Blood System for platelets. ... Dr. Shan was compensated $37,692 for consulting services in 2023. ... Under our director compensation program in effect for 2023, each non-employee director was entitled to an annual grant of RSUs on the date of each of our annual meetings ... Dr. Shan did not receive an RSU grant in 2023. ... The total for Dr. Shan is $82,692.

Data sourced from SEC filings. Last updated: 2026-03-05